Author | Year | Age | Sex | Location | Duration from primary diagnosis (years) | Immunostaining | 131I therapy | Survival (weeks) | ||
---|---|---|---|---|---|---|---|---|---|---|
TTF-1 | Tg | PAX-8 | ||||||||
Sumida et al. | 2000 | 60 | Female | Submandibular region | 7 | N/A | N/A | N/A | None | 20 |
Takeshita et al. | 2008 | 81 | Female | Liver | 3 | Negative | Focally | N/A | Yes | 16 |
Angeles-Angeles et al. | 2009 | 58 | Female | Breast | 20 | Focally | Focally | N/A | Yes | N/A |
Al-Qsous et al. | 2010 | 83 | Male | Lung | 10 | N/A | Weak | N/A | None | N/A |
Sotome et al. | 2010 | 82 | Female | Retroperitoneum | 18 | Negative | Negative | N/A | Yes | 2 |
Kaushal et al. | 2011 | 52 | Female | Shoulder | 8 | Positive | N/A | N/A | Yes | 8 |
Nakayama et al. | 2012 | 55 | Female | Pelvis | 12 | Negative | Negative | N/A | Yes | 14 |
Abe et al. | 2014 | 61 | Male | Lung | 10 | Positive | Negative | N/A | Yes | 24 |
Solomon et al. | 2015 | 64 | Male | Retroperitoneum | 28 | Weak | Negative | Positive | Yes | 3 |
Ambelil et al. | 2016 | 76 | Female | Mandible | 7 | Negative | Negative | Positive | Yes | N/A |
Kim et al. | 2017 | 61 | Female | Pleura | 19 | Positive | Negative | Positive | None | 16 |
Okuyama et al. | 2017 | 63 | Male | Lung | 49 | N/A | N/A | N/A | Yes | 20 |
Capron et al. | 2019 | 77 | Male | Pleura | 9 | Negative | Negative | Positive | Yes | N/A |
Present case | 2020 | 77 | Male | Mesentery | 6 | Negative | Negative | Positive | Yes | 4 |